Keyphrases
B-cell Lymphoma 2 (Bcl-2)
100%
Bcl-xL
100%
Mastocytosis
100%
Bone Marrow Lesions
100%
Mast Cells
45%
C-kit
27%
Bcl-2 Family Proteins
27%
Adult Patients
18%
Immunoblotting
9%
MRNA Level
9%
Quantitative PCR
9%
Apoptosis
9%
Healthy Controls
9%
Overexpression
9%
Overexpressing
9%
Pediatric Patients
9%
Immunoreactivity
9%
Rare Diseases
9%
Bone Marrow
9%
Immunohistochemistry
9%
Activating mutation
9%
Cell Culture
9%
Pediatric
9%
Skin Lesions
9%
Cell Apoptosis
9%
In Vitro Activation
9%
Prolonged Survival
9%
Cell Culture Model
9%
Human Mast Cells
9%
Mastocytoma
9%
Cutaneous Lesions
9%
Systemic Mastocytosis
9%
Cutaneous Mastocytosis
9%
Pediatric Mastocytosis
9%
Medicine and Dentistry
Bcl-xL
100%
Mastocytosis
100%
Mast Cell
60%
Messenger RNA
30%
Pediatrics
20%
Programmed Cell Death
20%
Skin Defect
20%
Cell Culture
20%
Protein Bcl 2
20%
In Vitro
10%
Pediatrics Patient
10%
Rare Disease
10%
Upregulation
10%
Immunohistochemistry
10%
Immunoblotting
10%
Immunoreactivity
10%
Urticaria Pigmentosa
10%
Systemic Mastocytosis
10%
Solitary Mastocytoma
10%
Protein Bcl Xl
10%
Diseases
10%
Reverse Transcription Polymerase Chain Reaction
10%
Pharmacology, Toxicology and Pharmaceutical Science
Mastocytosis
100%
Messenger RNA
33%
Cell Culture
22%
Protein Bcl 2
22%
Skin Defect
22%
Western Blot
11%
Rare Disease
11%
Protein Bcl Xl
11%
Mastocytoma
11%
Urticaria Pigmentosa
11%
Systemic Mastocytosis
11%
Diseases
11%